Humanised monoclonal antibody therapy for rheumatoid arthritis
- 26 September 1992
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 340 (8822) , 748-752
- https://doi.org/10.1016/0140-6736(92)92294-p
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Immunotherapy of rheumatoid arthritis.Annals of the Rheumatic Diseases, 1992
- Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasisThe Lancet, 1991
- The induction of skin graft tolerance in major histocompatibility complex‐mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti‐CD4 and anti‐CD8 antibodiesEuropean Journal of Immunology, 1990
- Genes associated with rheumatoid arthritis and mild inflammatory arthritis. II. Association of HLA with complement C3 and immunoglobulin Gm allotypes.Annals of the Rheumatic Diseases, 1990
- The CAMPATH‐1 antigen (CDw52)Tissue Antigens, 1990
- CAMPATH-1M—PROPHYLACTIC USE AFTER KIDNEY TRANSPLANTATIONTransplantation, 1989
- Manipulation of T-Cell Responses with Monoclonal AntibodiesAnnual Review of Immunology, 1989
- Reshaping human antibodies for therapyNature, 1988
- INCREASED INFECTIONS ASSOCIATED WITH THE USE OF OKT3 FOR TREATMENT OF STEROID-RESISTANT REJECTION IN RENAL TRANSPLANTATION1 Pressented at the 6th Annual Meeting of the American Society of Transplant Physicians, May 1987, Chicago, ILTransplantation, 1988
- Tolerance to rat monoclonal antibodies. Implications for serotherapy.The Journal of Experimental Medicine, 1986